These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12239460)

  • 1. Antiangiogenic effect of octreotide inhibits the growth of human rectal neuroendocrine carcinoma.
    Koizumi M; Onda M; Tanaka N; Seya T; Yamada T; Takahashi Y
    Digestion; 2002; 65(4):200-6. PubMed ID: 12239460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
    Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
    J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.
    Hashimoto K; Masumori N; Tanaka T; Maeda T; Kobayashi K; Kitamura H; Hirata K; Tsukamoto T
    Prostate; 2013 Apr; 73(5):500-11. PubMed ID: 22996996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice].
    Chen S; Xie Y; Wang CH; Tang CW
    Ai Zheng; 2009 Jul; 28(7):673-8. PubMed ID: 19624890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo].
    Wang C; Tang C
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):19-22. PubMed ID: 11953120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
    Wang CH; Tang CW
    Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.
    Waser B; Cescato R; Liu Q; Kao YJ; Körner M; Christ E; Schonbrunn A; Reubi JC
    Am J Pathol; 2012 May; 180(5):1942-9. PubMed ID: 22538189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
    Weckbecker G; Liu R; Tolcsvai L; Bruns C
    Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture.
    Lawnicka H; Stepień H; Wyczółkowska J; Kolago B; Kunert-Radek J; Komorowski J
    Biochem Biophys Res Commun; 2000 Feb; 268(2):567-71. PubMed ID: 10679244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
    Mohamed A; Blanchard MP; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Monges G; Garcia S; Ferone D; Florio T; Enjalbert A; Moutardier V; Schonbrunn A; Gerard C; Barlier A; Saveanu A
    Endocr Relat Cancer; 2014 Oct; 21(5):691-704. PubMed ID: 25012983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
    Zhao B; Zhao H; Zhao N; Zhu XG
    J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells.
    Mentlein R; Eichler O; Forstreuter F; Held-Feindt J
    Int J Cancer; 2001 May; 92(4):545-50. PubMed ID: 11304689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
    Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
    Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide augments the effects of hepatic arterial occlusion in treating a rat liver tumor model.
    Guo WJ; Zhuang JY; Bai YR; Li J; Cheng YF; Shen Z; Li WH; Zhang WZ; Cai R
    Hepatogastroenterology; 2003; 50(50):349-53. PubMed ID: 12749218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.
    Bauer AJ; Terrell R; Doniparthi NK; Patel A; Tuttle RM; Saji M; Ringel MD; Francis GL
    Thyroid; 2002 Nov; 12(11):953-61. PubMed ID: 12490072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
    Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
    Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.